IL132652A0 - Use of 1-ar(al)yl-imidazolin-2-one for treating anxiety and stress conditions - Google Patents

Use of 1-ar(al)yl-imidazolin-2-one for treating anxiety and stress conditions

Info

Publication number
IL132652A0
IL132652A0 IL13265298A IL13265298A IL132652A0 IL 132652 A0 IL132652 A0 IL 132652A0 IL 13265298 A IL13265298 A IL 13265298A IL 13265298 A IL13265298 A IL 13265298A IL 132652 A0 IL132652 A0 IL 132652A0
Authority
IL
Israel
Prior art keywords
imidazolin
stress conditions
treating anxiety
anxiety
treating
Prior art date
Application number
IL13265298A
Other languages
English (en)
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of IL132652A0 publication Critical patent/IL132652A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13265298A 1997-05-23 1998-05-14 Use of 1-ar(al)yl-imidazolin-2-one for treating anxiety and stress conditions IL132652A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19721580A DE19721580A1 (de) 1997-05-23 1997-05-23 Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
PCT/DE1998/001343 WO1998052548A2 (de) 1997-05-23 1998-05-14 Verwendung von 1-ar(alk)yl-imidazolin-2-one zur behandlung von angst- und spannungszuständen
US09/079,802 US5994347A (en) 1997-05-23 1998-05-15 For a process for treatment of anxiety and tension

Publications (1)

Publication Number Publication Date
IL132652A0 true IL132652A0 (en) 2001-03-19

Family

ID=26036759

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13265298A IL132652A0 (en) 1997-05-23 1998-05-14 Use of 1-ar(al)yl-imidazolin-2-one for treating anxiety and stress conditions

Country Status (25)

Country Link
US (1) US5994347A (hu)
EP (1) EP0979083B1 (hu)
JP (1) JP4838403B2 (hu)
CN (1) CN1150901C (hu)
AR (1) AR012746A1 (hu)
AT (1) ATE246926T1 (hu)
AU (1) AU745536B2 (hu)
BG (1) BG63378B1 (hu)
BR (1) BR9809666A (hu)
CA (1) CA2291075C (hu)
DE (2) DE19721580A1 (hu)
DK (1) DK0979083T3 (hu)
ES (1) ES2205516T3 (hu)
HU (1) HUP0003108A3 (hu)
IL (1) IL132652A0 (hu)
NO (1) NO325346B1 (hu)
NZ (1) NZ500849A (hu)
PL (1) PL193589B1 (hu)
PT (1) PT979083E (hu)
RU (1) RU2203055C2 (hu)
SK (1) SK284258B6 (hu)
TR (1) TR199902815T2 (hu)
TW (1) TW579294B (hu)
WO (1) WO1998052548A2 (hu)
ZA (1) ZA984197B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
CN101254189A (zh) * 2003-07-11 2008-09-03 埃尔比昂股份公司 用对苯并二氮杂䓬受体的α3亚基具有选择性的化合物治疗或预防中枢神经系统病症的方法
CA2576344C (en) 2004-08-11 2010-10-05 Cadbury Adams Usa Llc Warming compositions and delivery systems therefor
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US5869481A (en) * 1995-09-05 1999-02-09 Arzneitmittelwerk Dresden G.M.B.H. Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
DE19532668A1 (de) * 1995-09-05 1997-03-06 Dresden Arzneimittel Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
HUP0003108A2 (hu) 2001-05-28
RU2203055C2 (ru) 2003-04-27
EP0979083A2 (de) 2000-02-16
DK0979083T3 (da) 2003-12-01
PL337090A1 (en) 2000-07-31
DE59809285D1 (de) 2003-09-18
ES2205516T3 (es) 2004-05-01
WO1998052548A2 (de) 1998-11-26
BR9809666A (pt) 2000-07-11
ZA984197B (en) 1998-06-24
TW579294B (en) 2004-03-11
WO1998052548A3 (de) 1999-04-22
PT979083E (pt) 2003-12-31
AU745536B2 (en) 2002-03-21
PL193589B1 (pl) 2007-02-28
ATE246926T1 (de) 2003-08-15
DE19721580A1 (de) 1998-11-26
AU8332698A (en) 1998-12-11
JP2001525829A (ja) 2001-12-11
TR199902815T2 (xx) 2000-08-21
NO325346B1 (no) 2008-04-07
NO995300D0 (no) 1999-10-29
CA2291075A1 (en) 1998-11-26
US5994347A (en) 1999-11-30
NO995300L (no) 1999-10-29
BG103859A (en) 2000-07-31
CN1260717A (zh) 2000-07-19
CA2291075C (en) 2006-04-04
SK158499A3 (en) 2001-03-12
BG63378B1 (bg) 2001-12-29
SK284258B6 (sk) 2004-12-01
HUP0003108A3 (en) 2001-07-30
AR012746A1 (es) 2000-11-08
CN1150901C (zh) 2004-05-26
EP0979083B1 (de) 2003-08-13
JP4838403B2 (ja) 2011-12-14
NZ500849A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
EP1009415A4 (en) INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
DE69821759D1 (de) System zur identifizierung und korrektur anormaler oszillometrischer pulswellen
EP0988009A4 (en) DEVICE AND METHOD FOR TREATING DYSMENORRHEA
GB9827519D0 (en) Use of il and gas field chemicals
ZA9811644B (en) Method and equipment for refining silicon
DE59710130D1 (de) Verwendung verbindungsverfahrens und verbindungsverfahren
GB2338014B (en) Novel drilling device and method of use
HUP0003206A3 (en) Methods of preparing and purifying 9-nitro-20-camptothecin
EP0897523A4 (en) SEMICONDUCTOR BRIDGE DEVICE AND MANUFACTURING METHOD
GB2346823B (en) Reamer and method of using the same
EP1117395A4 (en) COMPOUNDS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISEASES AND THEIR PRODUCTION AND USE METHODS
IL125557A0 (en) Use of lhrh-analogs and anti-estrogens for treating gynaecological disorders
GB9819898D0 (en) New vaccine and method of use
HU9402209D0 (en) Device for consumption test and of permission gas-consumers
HUP0003958A3 (en) Process for preparation of 4-aryl-piperidines and intermediates
PL337716A1 (en) Method of obtaining thiazafurin and other c-nucleosides
IL132652A0 (en) Use of 1-ar(al)yl-imidazolin-2-one for treating anxiety and stress conditions
GB9715747D0 (en) Method of testing
HUP9800146A3 (en) Thalidomide-derivatives and use of them
PL342232A1 (en) Bridge girder and method of making same
SG87771A1 (en) Apparatus checking method and apparatus to which the same is applied
EP1027690A4 (en) COMMUNICATION DEVICE AND IMPLEMENTATION METHOD
GB9609843D0 (en) Fixing means and method of use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)

Owner name: ELBION GMBH

Free format text: FORMER NAME:ELBION AG

HP Change in proprietorship

Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH

Free format text: FORMER OWNER:ELBION GMBH

MM9K Patent not in force due to non-payment of renewal fees